Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pharmaceutical Cleaning Validation Market Outlook (2022 to 2032)

The Pharmaceutical Cleaning Validation market was valued at around US$ 15.7 Billion in 2021. With a projected CAGR of 6.8% for the next ten years, the market is likely to reach a valuation of nearly US$ 32.3 Billion by the end of 2032. The recent surge in stringent guidelines and regulations has triggered the demand for Cleaning Validations in the Pharmaceutical Industry.

Attributes Details
Pharmaceutical Cleaning Validation Market Size (2022E) US$ 16.7 Billion
Projected Market Value (2032F) US$ 32.3 Billion
Global Market Growth Rate (2022 to 2032) 6.8% CAGR
North America Market Share (2021) 40%
Key Companies Profiled
  • Shimadzu Corporation
  • Intertek Group PLC
  • Merck KGaA
  • SUEZ
  • Hach
  • Avomeen LLC
  • QPharma Inc.
  • SGS SA
  • ProPharma Group
  • Kymos S.L.
  • Waters Corporation
  • Lucideon Limited

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Pharmaceutical Cleaning Validation from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The global market for Cleaning Validations in the Pharmaceutical industry expanded at a CAGR of 6% from 2017 to 2021. The market growth is projected to augment because of updates and revisions to existing cleaning validation guidelines in the pharmaceutical sector along with the release of new guidelines. It is anticipated that organizations like the European Medicines Agency (EMA) will be instrumental in the increase in avenues for the key industry players shaping the Pharmaceutical Cleaning Validation Market in the forthcoming years.

The global Pharmaceutical Cleaning Validation market is predicted to surge ahead at a CAGR of 6.8% and record sales worth US$ 32.3 Billion by the end of 2032. The USA will continue to be the largest market throughout the analysis period accounting for over US$ 5.1 Billion absolute dollar opportunity in the coming 10-year epoch.

Which factors are propelling the Global Pharmaceutical Cleaning Validation Market during the forthcoming years?

European Medicines Agency (EMA) is the pacesetter with regard to the development of risk-based cleaning validation guidelines for the prevention of cross-contamination in numerous shared facilities for manufacturing across the globe. In May 2020, the Pharmaceutical Inspection Co-Operation Scheme (PIC/S), initiated documents containing guidelines and QnAs pertaining to the Implementation of Risk-based Prevention of Cross-Contamination in Production and the setting of Health-Based Exposure Limits (HBEL) in order to identify risks in the manufacturing of various pharmaceutical products in numerous shared facilities.

These regulations are based on the 2018 EMA guidelines. In 2021, the FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new novel therapeutics. As of November 2021, EMA’s Committee for Medicinal Products for Human Use (CHMP) issued recommendations for the approval of as many as 57 new medicines, vaccines, and therapeutic biologics, of which around 36 had been granted marketing authorization.

Owing to these newly approved drugs and therapeutics, the Pharmaceutical Cleaning Validation Market is set to witness growth during the forthcoming years, in order to keep up with the strict guidelines of regulatory agencies such as EMA and the USA FDA for cleaning validation processes.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Region-wise Insights

Why does Asia-Pacific Stand as the Most Lucrative Market for Pharmaceutical Cleaning Validation Market?

The driving factors behind the growth of the Pharmaceutical Cleaning Validation Market in the Asia-Pacific region during the forthcoming years are recognized to be the augmented funding by the intercontinental Pharmaceutical corporations in big production enterprises. In September 2019, the primordial ISPE Asia-Pacific Pharmaceutical Manufacturing Conference was arranged by the International Society of Pharmaceutical Engineering, and the following year, in September 2020, the second edition. Included among the considerable points of discussion were the control of cross-contamination and cleaning validation. As of 2020, the net sales of Shimadzu Corporation in Japan witnessed an increase of around 3% in comparison to the previous year.

Shimadzu Corporation’s sales in China rose by an extensive 20% in 2020 relative to that of 2019. This increase is mainly attributed to the increased requirement for Liquid chromatographs and mass spectrometers owing to Pharmacopoeia revisions. The Pharmaceutical Cleaning Validation Market in China is projected to witness a growth of 8.6% CAGR during the coming 10-year epoch to reach a total market valuation of US$ 4.1 Billion by the end of 2032. This is among the various attributes responsible for the growth of the Pharmaceutical Cleaning Validation Market in Asia-Pacific during the forthcoming years.

How is the Pharmaceutical Cleaning Validation Market in North America Shaping Up?

With a market share of approximately more than 40%, the Pharmaceutical Cleaning Validation Market in the North American region is expected to maintain its dominant position in the market during the forthcoming years. The binding guidelines of authorization organizations like the USA FDA and Health Canada have generated and augmented the requirement for cleaning validation processes in the Pharmaceutical Industry for the prevention of cross-contamination and expanding their control processes related to product quality.

The Cleaning Validation Guide (GUI-0028) published by Health Canada in June 2021, with its revised guidelines, lays heavy emphasis on a Cleaning Validation Master Plan or any equivalent document, outlining the general cleaning policies at the manufacturing site for any and all players in the Pharmaceutical Industry.

The FDA ensures complete compliance with the CGMP regulations by thoroughly examining the manufacturing procedures in the Pharmaceutical Industry. This is attributed to its Code of Federal Regulations (CFR). The 21 CFR Part 211 contains the Current Good Manufacturing Practice (CGMP) rules for Finished Pharmaceuticals. This is projected to be advantageous for the Pharmaceutical Cleaning Validation Market in the North-American region.

Country-wise Insights

USA Pharmaceutical Cleaning Validation Market Analysis

The USA is projected to keep its market share of over 30% in the Global Pharmaceutical Cleaning Validation Market intact with a CAGR of 6.5% during the forthcoming years. It is anticipated that the Pharmaceutical Cleaning Validation Market in the country will reach total market revenue of US$ 10.9 Billion by experiencing an absolute dollar opportunity of US$ 5.1 Billion during the forecast period.

Purdue University, collaborated with the USA pharmacopeia, beginning in August 2021, following impetus from Aprecia Pharmaceuticals, to advance the pharmaceutical validation market technology forum. Taking into account February 2021, Article of Aptitude Health, the USA FDA’s Center for Drug Evaluation and Research (CDER) approved as many as 53 novel drugs, both as new molecular entities (NMEs) and new therapeutic biologics in 2020. This is forecasted to have a positive impact on the role of the USA in the Global Cleaning Validation Demand in the Pharmaceutical Industry owing to the guidelines of the FDA, which emphasize strict adherence to the Cleaning Validation Procedures.

United Kingdom Pharmaceutical Cleaning Validation Market Analysis

The market in the United Kingdom is projected to reach a valuation of US$ 1.5 Billion by 2032. With a CAGR of 8% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 824 Million.

Japan Pharmaceutical Cleaning Validation Market Analysis

In Japan, the market is expected to reach US$ 1.2 Billion by 2032, growing at a CAGR of 6.7% during the forecast period. From 2022 to 2032, the market is likely to register an absolute dollar opportunity of US$ 577 Million.

South Korea Pharmaceutical Cleaning Validation Market Analysis

The market in South Korea is expected to reach a valuation of US$ 614 Million by 2032. With a CAGR of 6.3% during the forecast period, the market is likely to gross an absolute dollar opportunity of US$ 281 Million.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

How has the Increasing Use of Product-specific Analytical Tests Impacted the Pharmaceutical Cleaning Validation Market?

The Product-specific Analytical Tests segment is anticipated to expand with a CAGR of 6.4% by the end of 2032. The Product-Specific Analytical Test segment is forecasted to benefit from the increase in the requirement for High-Performance Liquid Chromatography (HPLC) testing, due to its growing importance in the procedures related to drug approvals. The customary use of High-Performance Liquid Chromatography (HPLC) testing during the manufacturing procedures of the Pharmaceutical Industry finds additional corroboration in the fact that it provides required precise results, further helping the key market players to be on par with the various guidelines of the regulatory agencies during the upcoming 10-year forecast epoch.

How is Cleaning Validation Demand in the Pharmaceutical Industry Expected to Perform with their Growing Necessity in the Small Molecule Drug segment by product type?

The Small Molecule Drug segment is forecasted to grow with an 8.1% CAGR during the 10-year epoch. Factors like the FDA’s Center for Drug Evaluation and Research (CDER) granting authorization to as many as 53 recent drugs, 38 of which were small molecule drugs in 2020 are projected to be advantageous to the Small Molecule Drug segment by Product-type of the Pharmaceutical Cleaning Validation Market during the forthcoming years.

Even in 2021, with 34 approvals the small molecule drugs made up half of as many as 50 novel drug approvals. Due to the stringent guidelines and regulations of the authorities like the EMA (European Medicines Agency) and the USA FDA (USA Food and Drug Administration), the requirement for better cleaning validation in these increasing levels of production of Small Molecule Drugs is set to rise, leading to better avenues for the key players of the Pharmaceutical Cleaning Validation Industry during the upcoming 10-year forecast epoch.

Competitive Analysis

Shimadzu Corporation, Intertek Group PLC, Merck KGaA, SUEZ, Hach, Avomeen LLC, QPharma Inc., SGS SA, ProPharma Group, Kymos S.L., Waters Corporation, and Lucideon Limited are among the key players in the global pharmaceutical cleaning validation market.

Some of the recent developments in the market are:

  • In August 2022, a partnership was announced between Merck KGaA and Agilent Technologies for filling the industry gap encountered in Process Analytical Technologies for Downstream Processing.
  • In December 2020, the Sievers TOC (Total Organic Carbon) online analyzer, the M500, was initiated by Suez keeping in mind life science and pharmaceutical businesses. The aim of this high-order analyzer is to improve efficiency by reducing the time taken to analyze the organic carbon levels by 50%, it also has additional features including WIFI prospects, better security features for data integrity protection, and elevated data transferring capacity.
  • In August 2020, Shimadzu Corporation contrived a vital collaboration with HORIBA Ltd. Keeping in mind the production and marketing of LC-Raman analytical and measuring devices, by bringing together their assets and abilities.

Key Segments Covered in Market Survey

By Validation Test:

  • Non-specific Tests
    • Total Carbon Analysis (TC)
    • Total Organic Carbon Testing (TOC)
    • Non-purgeable Organic Carbon (NPOC)
    • Conductivity
    • Other Non-specific Tests
  • Product-specific Analytical Tests
    • Ultraviolet-Visible Spectroscopy (US/VIS)
    • High-Performance Liquid Chromatography (HPLC)
    • Liquid Chromatography/Mass Spectrometry (LC/MS)
    • Other Product-specific Analytical Tests

By Product Type:

  • Small Molecule Drug
  • Peptides
  • Proteins
  • Cleaning Detergent

By Region:

  • North America
    • The USA
    • Canada
  • The Asia Pacific
    • China
    • Japan
    • South Korea
    • India
  • Europe
    • Germany
    • United Kingdom
    • France
    • Russia
    • Italy
  • The Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • United Arab Emirates(UAE)
    • Nigeria
    • Egypt
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia

Frequently Asked Questions

How much is the Pharmaceutical Cleaning Validation market currently worth

The Pharmaceutical Cleaning Validation market was valued at US$ 15.7 Billion in 2021.

What is the Hyaluronic Raw Material Market Forecast through 2032?

The Pharmaceutical Cleaning Validation industry is set to witness a growth rate of 6.8% over the forecast period and be valued at US$ 32.3 Billion by 2032.

Whom are the key players shaping the Pharmaceutical Cleaning Validation industry?

Shimadzu Corporation, Intertek Group PLC, Merck KGaA, Suez, Hach, Avomeen, QPharma Inc., SGS SA, ProPharma Group, Kymos S.L., Waters Corporation, and Lucideon Limited are among the key players shaping the Pharmaceutical Cleaning Validation Industry.

Which is a key trend in the Pharmaceutical Cleaning Validation market?

The continuous revision and expansion of guidelines for cleaning validation by regulatory agencies such as EMA and the U.S. FDA and the increase in the number of approved therapeutics and medicines are anticipated to favorably impact the global demand for cleaning validation in the Pharmaceutical Industry.

What is the USA market outlook for Pharmaceutical Cleaning Validation?

The market in the USA is expected to reach a valuation of US$ 10.9 Billion during the forecast period along with a CAGR of 6.5%

Which region is expected to show significant growth during the forecast period?

The Asia Pacific market is expected to grow significantly during the forecast period mainly due to increasing awareness of the requirement of cleaning validation processes in the Pharmaceutical Industry, especially in China.

Table of Content

1. Executive Summary | Pharmaceutical Cleaning Validation Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Validation Test

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Validation Test, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Validation Test, 2022 to 2032

        5.3.1. Non-specific Tests

            5.3.1.1. Total Carbon Analysis (TC)

            5.3.1.2. Total Organic Carbon Testing (TOC)

            5.3.1.3. Non-purgeable Organic Carbon (NPOC)

            5.3.1.4. Conductivity

            5.3.1.5. Other Non-specific Tests

        5.3.2. Product-specific Analytical Tests

            5.3.2.1. Ultraviolet-Visible Spectroscopy (UV/VIS)

            5.3.2.2. High-Performance Liquid Chromatography (HPLC)

            5.3.2.3. Liquid Chromatography/ Mass Spectrometry (LC/MS)

            5.3.2.4. Other Product-specific Analytical Tests

    5.4. Y-o-Y Growth Trend Analysis By Validation Test, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Validation Test, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032

        6.3.1. Small Molecule Drug

        6.3.2. Peptides

        6.3.3. Proteins

        6.3.4. Cleaning Detergent

    6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa(MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Validation Test

        8.2.3. By Product Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Validation Test

        8.3.3. By Product Type

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Rest of Latin America

        9.2.2. By Validation Test

        9.2.3. By Product Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Validation Test

        9.3.3. By Product Type

    9.4. Key Takeaways

10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. United Kingdom

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Validation Test

        10.2.3. By Product Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Validation Test

        10.3.3. By Product Type

    10.4. Key Takeaways

11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Validation Test

        11.2.3. By Product Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Validation Test

        11.3.3. By Product Type

    11.4. Key Takeaways

12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Validation Test

        12.2.3. By Product Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Validation Test

        12.3.3. By Product Type

    12.4. Key Takeaways

13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Validation Test

        13.2.3. By Product Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Validation Test

        13.3.3. By Product Type

    13.4. Key Takeaways

14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Rest of Middle East and Africa(MEA)

        14.2.2. By Validation Test

        14.2.3. By Product Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Validation Test

        14.3.3. By Product Type

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Validation Test

            15.1.2.2. By Product Type

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Validation Test

            15.2.2.2. By Product Type

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Validation Test

            15.3.2.2. By Product Type

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Validation Test

            15.4.2.2. By Product Type

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Validation Test

            15.5.2.2. By Product Type

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Validation Test

            15.6.2.2. By Product Type

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Validation Test

            15.7.2.2. By Product Type

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Validation Test

            15.8.2.2. By Product Type

    15.9. United Kingdom

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Validation Test

            15.9.2.2. By Product Type

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Validation Test

            15.10.2.2. By Product Type

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Validation Test

            15.11.2.2. By Product Type

    15.12. BENELUX

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Validation Test

            15.12.2.2. By Product Type

    15.13. China

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Validation Test

            15.13.2.2. By Product Type

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Validation Test

            15.14.2.2. By Product Type

    15.15. South Korea

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Validation Test

            15.15.2.2. By Product Type

    15.16. India

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Validation Test

            15.16.2.2. By Product Type

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Validation Test

            15.17.2.2. By Product Type

    15.18. Malaysia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Validation Test

            15.18.2.2. By Product Type

    15.19. Indonesia

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Validation Test

            15.19.2.2. By Product Type

    15.20. Australia

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Validation Test

            15.20.2.2. By Product Type

    15.21. New Zealand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Validation Test

            15.21.2.2. By Product Type

    15.22. GCC Countries

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Validation Test

            15.22.2.2. By Product Type

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Validation Test

        16.3.3. By Product Type

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Shimadzu Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Sales Footprint

            17.1.1.4. Strategy Overview

            17.1.1.5. Marketing Strategy

                17.1.1.5.1. Product Strategy

                17.1.1.5.2. Channel Strategy

        17.1.2. Intertek Group PLC

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Sales Footprint

            17.1.2.4. Strategy Overview

            17.1.2.5. Marketing Strategy

                17.1.2.5.1. Product Strategy

                17.1.2.5.2. Channel Strategy

        17.1.3. Merck KGaA

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Sales Footprint

            17.1.3.4. Strategy Overview

            17.1.3.5. Marketing Strategy

                17.1.3.5.1. Product Strategy

                17.1.3.5.2. Channel Strategy

        17.1.4. SUEZ

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Sales Footprint

            17.1.4.4. Strategy Overview

            17.1.4.5. Marketing Strategy

                17.1.4.5.1. Product Strategy

                17.1.4.5.2. Channel Strategy

        17.1.5. Hach

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Sales Footprint

            17.1.5.4. Strategy Overview

            17.1.5.5. Marketing Strategy

                17.1.5.5.1. Product Strategy

                17.1.5.5.2. Channel Strategy

        17.1.6. Avomeen LLC

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Sales Footprint

            17.1.6.4. Strategy Overview

            17.1.6.5. Marketing Strategy

                17.1.6.5.1. Product Strategy

                17.1.6.5.2. Channel Strategy

        17.1.7. QPharma Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Sales Footprint

            17.1.7.4. Strategy Overview

            17.1.7.5. Marketing Strategy

                17.1.7.5.1. Product Strategy

                17.1.7.5.2. Channel Strategy

        17.1.8. SGS SA

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Sales Footprint

            17.1.8.4. Strategy Overview

            17.1.8.5. Marketing Strategy

                17.1.8.5.1. Product Strategy

                17.1.8.5.2. Channel Strategy

        17.1.9. ProPharma Group

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Sales Footprint

            17.1.9.4. Strategy Overview

            17.1.9.5. Marketing Strategy

                17.1.9.5.1. Product Strategy

                17.1.9.5.2. Channel Strategy

        17.1.10. Kymos S.L.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Sales Footprint

            17.1.10.4. Strategy Overview

            17.1.10.5. Marketing Strategy

                17.1.10.5.1. Product Strategy

                17.1.10.5.2. Channel Strategy

        17.1.11. Waters Corporation

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Sales Footprint

            17.1.11.4. Strategy Overview

            17.1.11.5. Marketing Strategy

                17.1.11.5.1. Product Strategy

                17.1.11.5.2. Channel Strategy

        17.1.12. Lucideon Limited

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Sales Footprint

            17.1.12.4. Strategy Overview

            17.1.12.5. Marketing Strategy

                17.1.12.5.1. Product Strategy

                17.1.12.5.2. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 2: Global Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 3: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 5: North America Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 8: Latin America Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 9: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 11: Europe Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 12: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 13: East Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 14: East Asia Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 15: East Asia Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 16: South Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 17: South Asia Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 18: South Asia Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 20: Oceania Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 21: Oceania Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 22: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 23: MEA Market Value (US$ Million) Forecast by Validation Test, 2017 to 2032

Table 24: MEA Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

List of Charts

Figure 1: Global Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 2: Global Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 7: Global Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 8: Global Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 9: Global Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 10: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 11: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 13: Global Market Attractiveness by Validation Test, 2022 to 2032

Figure 14: Global Market Attractiveness by Product Type, 2022 to 2032

Figure 15: Global Market Attractiveness by Region, 2022 to 2032

Figure 16: North America Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 17: North America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 22: North America Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 25: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 28: North America Market Attractiveness by Validation Test, 2022 to 2032

Figure 29: North America Market Attractiveness by Product Type, 2022 to 2032

Figure 30: North America Market Attractiveness by Country, 2022 to 2032

Figure 31: Latin America Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 32: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 37: Latin America Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 40: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 43: Latin America Market Attractiveness by Validation Test, 2022 to 2032

Figure 44: Latin America Market Attractiveness by Product Type, 2022 to 2032

Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 46: Europe Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 47: Europe Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 52: Europe Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 55: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 58: Europe Market Attractiveness by Validation Test, 2022 to 2032

Figure 59: Europe Market Attractiveness by Product Type, 2022 to 2032

Figure 60: Europe Market Attractiveness by Country, 2022 to 2032

Figure 61: East Asia Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 62: East Asia Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 63: East Asia Market Value (US$ Million) by Country, 2022 to 2032

Figure 64: East Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 65: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 66: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 67: East Asia Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 68: East Asia Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 69: East Asia Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 70: East Asia Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 71: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 72: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 73: East Asia Market Attractiveness by Validation Test, 2022 to 2032

Figure 74: East Asia Market Attractiveness by Product Type, 2022 to 2032

Figure 75: East Asia Market Attractiveness by Country, 2022 to 2032

Figure 76: South Asia Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 77: South Asia Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 78: South Asia Market Value (US$ Million) by Country, 2022 to 2032

Figure 79: South Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 80: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 81: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 82: South Asia Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 83: South Asia Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 84: South Asia Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 85: South Asia Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 88: South Asia Market Attractiveness by Validation Test, 2022 to 2032

Figure 89: South Asia Market Attractiveness by Product Type, 2022 to 2032

Figure 90: South Asia Market Attractiveness by Country, 2022 to 2032

Figure 91: Oceania Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 92: Oceania Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 93: Oceania Market Value (US$ Million) by Country, 2022 to 2032

Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 97: Oceania Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 98: Oceania Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 100: Oceania Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 101: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 102: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 103: Oceania Market Attractiveness by Validation Test, 2022 to 2032

Figure 104: Oceania Market Attractiveness by Product Type, 2022 to 2032

Figure 105: Oceania Market Attractiveness by Country, 2022 to 2032

Figure 106: MEA Market Value (US$ Million) by Validation Test, 2022 to 2032

Figure 107: MEA Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 108: MEA Market Value (US$ Million) by Country, 2022 to 2032

Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 112: MEA Market Value (US$ Million) Analysis by Validation Test, 2017 to 2032

Figure 113: MEA Market Value Share (%) and BPS Analysis by Validation Test, 2022 to 2032

Figure 114: MEA Market Y-o-Y Growth (%) Projections by Validation Test, 2022 to 2032

Figure 115: MEA Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 116: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 117: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 118: MEA Market Attractiveness by Validation Test, 2022 to 2032

Figure 119: MEA Market Attractiveness by Product Type, 2022 to 2032

Figure 120: MEA Market Attractiveness by Country, 2022 to 2032

Recommendations

Healthcare

Specialty Active Pharmaceutical Ingredient Market

Published : October 2023

Healthcare

Anti-Neoplastic Pharmaceutical Agents Market

Published : November 2022

Explore Healthcare Insights

View Reports

Pharmaceutical Cleaning Validation Market